Investinor, Industrifonden lead SEK96m Series C for Sweden’s Pharmalink

Norwegian investment firm Investinor has co-led a SEK96m Series C round for Swedish specialty pharmaceutical company Pharmalink AB alongside existing backer Industrifonden.